C h r o m a t o b i o a u t o g r a p h y fibroblasts c o b a l a m i n s rnethylmalonic aciduria
In recent years a number of patients have been described who suffer from inborn errors affecting the activity of one or both of the enzymes which in mammals are known to require cobalamin (Cbl) derivatives as coenzymes. Most frequently reported have been patients with methylmalonic aciduria due to deficient activity of rnethylrnalonyl-CoA CoA-carbonylrnutase (methylmalonyl-CoA mutase, EC 5.4.99.2). Such patients may either have a defective mutase apoenzyme, or may be unable to accumulate normal amounts of the coenzyme, AdoCbl (20, 28) . The latter group has recently been further divided on the basis of whether or not cell extracts are able to carry out normal synthesis of AdoCbl when incubated anaerobically with OH-Cbl, ATP, FAD, and dithiothreitol (15) . A less frequently reported group of patients exhibit both methylmalonic aciduria, and hornocystinuria due, respectively, to lack of activity of methylmalonyl-CoA mutase and of 5-methyltetrahydrofolate-homocysteine methyltransferase (EC 2.1.1.13) (3, 6, (23) (24) (25) . The latter enzyme requires MeCbl as cofactor. The tissues of these patients accumulate neither AdoCbl nor MeCbl (3, 17, 23) . Thus, there is ample evidence that the includes several subgroups with various abnormalities in the metabolic handling of cobalamins. A newly developed technique which has proven useful for gaining insight into many aspects of cobalamin metabolism is that of two-dimensional chromatobioautography (1 1, 13, 14) . This method permits the sensitive and specific determination of individual cobalamin derivatives in small samples of plasma or tissue. We have applied this technique to the study of cobalamins in fibroblasts cultured from patients with various forms of methylmalonic aciduria. In this paper we report the results of this study, as well as the results of cobalamin analyses of fibroblasts cultured from normal control subjects.
METHODS
Cultures were initiated from skin biopsies and fibroblasts were grown and harvested as described previously (25) . The same lot of serum supplement for the culture medium was used throughout. For studies of the effect of added OH-Cbl, cells were grown in complete darkness either in the presence of basal medium (containing 0.04-0.07 pmol/rnl Cbl), or in the same basal medium with OH-Cbl added as specified in the individual experiments. The cells were re-fed after 2 and 4 days, and on day 5 they were harvested under the illumination provided by a 25-watt red bulb (Westinghouse) filtered through a Kodak safelight # l A filter and a Wratten no. 70 filter. Cells were counted by use of a Coulter counter. For estimation of fibroblast cobalamins, the weighed cell pellet WAS dispersed in 5 ml water, and a 2-mi aliquot was taken for the estimation of AdoCbl, MeCbl, OH-Cbl, and CN-Cbl by a two-dimensional chromatobioautographic method (13, 14) . Precuations were taken to avoid exposure of samples to light. Total vitamin B,, was estimated on I-ml aliquots of cell suspension by a radioisotopic assay (19) . Total nitrogen was estimated by an automated micro-Kjeldahl method (30) using a continuous digester and a modified digestion mixture of 95% sulfuric acid containing 30 g selenium dioxide and 10 ml perchloric acid/liter (9) .
SUBJECTS
The control lines of fibroblasts used were obtained from healthy individuals free of known metabolic abnormalities. These fibroblasts had been included as normal controls in previous studies of the rates of conversion of [I-"Clpropionate to 14COz by intact cells, and of the activities of 5-methyltetrahydrofolate-homocysteine methyltransferase in cell extracts (25) and were comparable with other control cell lines in these respects.
Cells were studied from six patients with methylmalonic aciduria. The available evidence suggests that these patients fall into at least three groups classified as follows. E M , a male, died at 7.5 weeks with methylmalonic aciduria and homocystinuria (10) . Cultured fibroblasts have defects in propionate oxidation and homocysteine methylation which are (at least partially) repaired by growth in the presence of high concentrations of OH-Cbl. 5-Methyltetrahydrofolate-homocysteine methyltransferase activity in fibroblast extracts was very low in the absence of added MeCbl, but almost normal in the presence of added MeCbl (25) . Liver and kidney contained abnormally low concentrations of AdoCbl (23 (17) .
M M , a female child, died at 7 years with methylmalonic aciduria and evidence of disturbed homocysteine metabolism. Liver extracts converted methylmalonyl-CoA to succinate abnormally slowly unless AdoCbl was added. 5-Methyltetrahydrofolatehomocysteine methyltransferase activity in fibroblast extracts was very much below normal unless MeCbl was added. Liver, kidney, spleen, and brain contained abnormally low concentrations of all forms of cobalamins (3).
J R , a male, now 19 years, had methylmalonic aciduria and homocystinuria. N o defect in propionate oxidation was demonstrable in intact cultured fibroblasts (6, 8) . 5-Methyltetrahydrofolate-homocysteine methyltransferase activity in fibroblast extracts was abnormally low without added MeCbl, but virtually normal with added MeCbl (6) .
M R , a male child, now 8 years, had methylmalonic aciduria and homocystinuria, and was a brother of J R . Findings with cultured fibroblasts were essentially the same as with fibroblasts of J R (6).
RESULTS
For the present studies, each line of fibroblasts was grown in the presence of four concentrations of cobalamin, ranging from the 0.04-0.07 pmol/mi contained in the basal medium, to 74 pmol/ml (100 ng/ml), added in the form of OH-Cbl. Each cell preparation was analyzed for total colbalamin content, and, by two-dimensional chromatobioautography, for the specific derivatives, AdoCbl, MeCbl, OH-Cbl, and cyanocobalamin (CN-Cbl). The results, expressed a s cobalamin content per 10 mg cellular nitrogen, are presented in Table 1 . In this table, the indivudual compounds are given also as percentages of total cellular cobalamin. For some cell lines, more than one experiment was carried out. The values entered are the means of the individual experiments. Three lines of fibroblasts from normal control subjects were studied. The values are listed as means * 1 S D .
These control cells, when grown in the basal medium, contained substantial ~rooortions of both MeCbl and AdoCbl. with the a a former predominating. As increasing concentrations df OH-Cbl were added to the growth medium, the total cellular cobalamin content increased progressively, up to approximately 20-fold the concentration under basal conditions. The changes in the individual cobalamins were approximately commensurate, so that the percentage distributions of MeCbl, AdoCbl, and OH-Cbl did not change markedly. Under no circumstances were significant amounts of CN-Cbl detected in the control cells. When the data were expressed in terms of cell number, rather than on the basis of cellular nitrogen (Fig. I) , the patterns of cobalamin concentration were similar. The slight differences which were present do not affect any of the substantive conclusions arrived at subsequently in this presentation. Three different patterns of response were discernable in the cells cultured from patients with methylmalonic aciduria, as can be seen in Table 1 and Figure 1 , and described as follows.
FIBROBLAST LINES Group a. One fibroblast line, that from M O , had no apparent abnormality in cobalamin accumulation. Total Cbl, MeCbl, AdoCbl, and OH-Cbl were essentially within normal limits, and increased normally as OH-Cbl was added to the growth medium.
Group b. One line of cells, that from K B , contained virtually no AdoCbl under any of the cultural condi:ions. In these cells the MeCbl contents and proportions were higher than normal, the OH-Cbl below normal, but the total cobalamin concentrations were in the normal range.
Group c. Four cell lines, those from E M , M M , J R , and M R , had multiple abnormalities. Each of these lines had decreased concentrations and decreased proportions of MeCbl, although this trend was less marked for cells from J R and M R , especially when the cells were grown at low concentrations of cobalamin. As OH-Cbl was added to the growth medium, MeCbl concentrations increased. The proportions of this compound remained approximately the same. Thus, cells grown at the highest concentration of OH-Cbl contained as much, or more MeCbl than did normal control cells grown in the basal medium.
Similar patterns were seen for the cellular concentrations of AdoCbl. For this compound, the deficits in concentrations appeared to be less severe, and the proportions were on the whole normal. Again, the cellular AdoCbl concentrations rose as O HCbl was added to the growth medium. In three instances, a medium concentration as low as 7.4 pmol/ml led to cellular concentrations higher than the mean for control cells grown in the basal medium.
These cell lines had low or low normal concentrations of OH-Cbl. The net results of all these changes were decreased cellular concentrations of total Cbl.
It was only in cells among this group (and in single samples from K B and M O ) that significant amounts of CN-Cbl were detected. In no instance was the proportion of this compound more than 13% of the total Cbl ( M R cells grown in basal medium). The presence of CN-Cb was not observed consistently in repeated experiments.
DISCUSSION
The results reported here are, to our knowledge, the first complete analyses of cobalamin concentrations and distributions in cultured human fibroblasts. For control cells grown in our basal medium we find mean concentrations of 0.67 pmol MeCbl/108 cells and 0.34 pmol AdoCbl/108 cells. Since approximately 2 x lo8 cells comprise 1 g wet weight, these values are equivalent for MeCbl and AdoCbl, respectively, to 1.34 and 0.68 pmol/g wet weight cells. Addition of 0.74 pmol/ml OH-Cbl to the growth medium brought about rises in these concentrations to 2.24 and 1.66 pmol/g. These values may be compared with those reported by Mahoney and coworkers using a radioisotopic technique (16, 17) . For control human fibroblasts grown in basal medium ' Fibroblasts were grown as described under Merhods. 
S E M ) .
T h e concentrations of MeCbl and AdoCbl in fibroblasts grown in our basal medium are not particularly high when compared with the adult human tissues richest in these compounds. For example, liver, kidney, spleen, brain, and pituitary contain from 5-35 pmol MeCbl/g wet weight, and from 17-414 pmol AdoCbllg (12) . In the cultured fibroblasts, MeCbl is present at higher concentrations than is AdoCbl. In this respect, these cells differ in general from adult human tissues (in which AdoCbl is the major cobalamin (I I)), but resemble fetal tissues. MeCbl is the major cobalamin in fetal liver, kidney, spleen, and brain (I I). It should be realized, also, that is is extremely difficult to relate the cobalamin concentrations found in the present experiments to the concentrations which might exist in fibroblasts in vivo. Not only is the concentration of cobalamin in the interstitial fluid unknown, but cellular uptake of cobalamins in vivo may well be markedly facilitated by binding proteins not present in the growth medium used in the present experiments ( I , 2, 4, 7, 26, 27, 32, 33).
In gel-filtered extracts of normal control human fibroblasts grown in our basal medium, about 50% of the enzyme, 5-methyltetrahydrofolate-homocysteine methyltransferase, is found as an apoenzyme activatable by in vitro addition of MeCbl, and about 50% in the form of a holoenzyme (25) . The latter may already be complexed to a cobalamin, either MeCbl or a demethylated derivative which would be recovered in our assay as OH-Cbl. T h e present results indicate that under basal conditions cellular Cbl may be present in such low concentrations as to be limiting in holoenzyme formation. T h e lo8 fibroblasts which contain 0.67 pmol MeCbl and 0.88 pmol OH-Cbl (Fig. 1) would yield approximately 15 mg soluble protein (31) . Even if the methyltransferase has a molecular weight as high as lo6, and represents no more than one part in l o 4 of the soluble cellular protein, this enzyme would be present in amounts stoichiometric with MeCbl + OH-Cbl. If the enzyme is smaller, or if it represents a higher portion of the protein, the methyltransferase will exceed these cobalamins. This line of reasoning suggests that most, perhaps all, of the fibroblast MeCbl will normally be complexed to methyltransferase apoenzyme. Perhaps a major portion of the material recoverable as OH-Cbl will be complexed also (34) . Limitation of holoenzyme formation by available Cbl is compatible with the observations that as OH-Cbl is increased in the growth medium, and brings about a 22-fold increase in cellular MeCbl + OH-Cbl (Table I, Fig. I ) holoenzyme comes to represent more than 90% of the total 5-methyltetrahydrofolate-homocysteine methyltransferase activity. Concomitantly there is a 2.5-fold increase in the total amount of functional protein of this enzyme (25) .
For fibroblasts cultured from patients with methylmalonic aciduria the present results for each patient are in agreement with the variety of evidence (reviewed above) which indicates that: (1) MO had a defect in formation of methylmalonyl-CoA mutase apoenzyme but no abnormality of cobalamin metabolism; (2) K B was unable to form AdoCbl, but could form at least normal amounts of MeCbl; ( 3 ) E M , M M , J R , and M R were unable to accumulate normal amounts of either MeCbl or AdoCbl. This is the first direct demonstration of such defects in J R and M R cells. Each of these four cell lines presumably has a lesion affecting a step in the cellular uptake or early metabolism of cobalamin which is involved in the formation of both MeCbl and AdoCbl. However, as has been pointed out previously, the available evidence does not permit exact definition of the specific lesion in any single case. Furthermore, it is possible that not each of these cell lines is affected at the same metabolic site (3) .
One of the purposes of growing the fibroblasts at a range of Cbl concentrations was to investigate whether any particular Cbl concentration was especially useful in bringing out the metabolic abnormalities present in the mutant cell lines. In these experiments, deviations from normal appeared most strikingly in the mutant cells grown in medium containing 0.74-7.4 pmol OH-Cbl/ ml. However, the most convincing results for any given cell line were obtained by examining the patterns of cellular cobalamins over the entire range investigated.
The data on the cobalamin contents of the four lines of fibroblasts comprising group c suggest that in none of this group of oatients was the metabolic block comolete. For each cell line. the addition of OH-Cbl to the growth medium led to rises of cellular MeCbl and AdoCbl to concentrations which were comparable with those found in control cells grown in the presence of lower amounts of cobalamin. These results correlate with the clinical observation that the methylmalonic aciduria o f J R was greatly decreased after treatment with high doses of OH-Cbl (5). It has also been shown that fibroblasts from E M grown in the presence of high concentrations of OH-Cbl metabolized propionate at almost a normal rate and possessed a small amount of Ns-methyltetrahydrofolatehomocysteine methyltransferase holoenzyme (25) .
In contrast, the inability of cells from K B to accumulate AdoCbl showed no signs of being overcome by OH-Cbl addition. Even at the highest concentration of this compound tested, K B fibroblasts contained virtually no detectable AdoCbl (Table 1 and Fig. 1 ). This child received a large dose of OH-Cbl 12 18 hr before her death, but showed no clinical benefit. Unfortunately, because of the brief time involved, this trial must be regarded as inconclusive (18) . Among the group of patients whose fibroblasts (and other tissues) do not accumulate AdoCbl, most are clinically responsive to large doses of cobalamins, but some are not (21) . Since clinical responsiveness of a genetically determined metabolic disease to vitamin therapy is likely to require the presence of at least a small residual activity of the affected enzyme (22) . it would not be surprising if in some patients the lesion preventing AdoCbl formation was so complete that it could not be alleviated by increasing the available cobalarnin substrate. The evidence suggests that K B was such a patient.
Taken together, the findings reported here indicate that twodimensional chromatobioautography is useful in the study of patients with methylmalonic aciduria. Not only does this technique permit direct demonstration of defects in cobalamin metabolism but it allows, in addition, investigation of possible correlations between the responses of whole cells to cobalamin supplementation and the effectiveness of such compounds in the clinical treatment of patients.
S U M M A R Y Two-dimensional chromatobioautography has been used to study the cellular contents of OH-Cbl, CN-Cbl, MeCbl, and AdoCbl in several lines of fibroblasts cultured from normal control subjects and grown in the presence of increasing concentrations of OH-Cbl. These cells are unlike most adult human tissues, but similar to fetal tissues, in that MeCbl is the predominant alkylated cobalamin derivative. When grown in the presence of high concentrations of OH-Cbl, these normal fibroblasts were able to form increased amounts of both AdoCbl and MeCbl. The low concentrations of cobalamins under basal conditions may limit the accumulation of 5-methyltetrahydrofolate-homocysteine methyltransferase holoenzy me.
Cobalamin concentrations and distributions were determined also in six lines of fibroblasts cultured from patients with various forms of methylrnalonic aciduria. One line had no abnormality of cobalamin metabolism, but was defective in formation of methylmalonyl-CoA mutase apoenzyme. One line accumulated virtually no AdoCbl, but did form at least normal amounts of MeCbl. Four cell lines did not accumulate normal amounts of either AdoCbl or MeCbl. The responses of these mutant cell lines to growth in the presence of high concentrations of OH-Cbl correlate with the clinical responsiveness of at least some of the patients in question to treatment with cobalamins.
